Fda Trial
- All
- News
- Videos
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
FDA Push For Fake Brain Surgery Trial Spurs Ethical Concerns
The FDA's request, intended to conclusively determine the therapy's potency, has raised concerns the trial would be both unethical and impractical.
-
Harvard's Proven 5-Step Formula For Sharper Memory Doesn't Depend On Supplements
A survey has proven that 1 in 4 adults is dependent on brain supplements to make their memory sharper. Here is what the research about brain supplements usage and their effectiveness and a 5-step formula to actually make your memory sharper.
-
Pig Organ Transplants May One Day Outperform Human Donors, Says Leading Surgeon
A US clinical trial using gene-edited pig kidneys has begun, with experts saying xenotransplantation could one day offer safer and more effective alternatives to human donor organs.
-
Elon Musk's Neuralink to Test Brain Chips in Clinical Study in Great Britain
Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts.
-
Can Artificial Intelligence Chatbots Really Improve Mental Health
Recently, I found myself pouring my heart out, not to a human, but to a chatbot named Wysa on my phone. It nodded - virtually - asked me how I was feeling and gently suggested trying breathing exercises.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
Elon Musk's Neuralink Gets FDA's 'Breakthrough Device' Tag for Implant Aimed at Restoring Vision
Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the US Food and Drug Administration's "breakthrough device" designation.
-
Neuralink Brain Chip Implant Wires Now Stable in First Patient, Musk Hopes for More Human Trials This Year
Neuralink's first brain chip implant in a human has stabalised, company executives have confirmed this week. The device works by using tiny wires, which are thinner than a human hair, to capture signals from the brain and translate those into actions such as moving a mouse cursor on a computer screen.
-
Higher-Dose Wegovy Gets US Nod, Trials Show Over 20% Average Weight Loss, Says Drugmaker
Novo Nordisk said it plans to launch the new formulation, (semaglutide 7.2 mg), in the United States in April 2026.
-
FDA Push For Fake Brain Surgery Trial Spurs Ethical Concerns
The FDA's request, intended to conclusively determine the therapy's potency, has raised concerns the trial would be both unethical and impractical.
-
Harvard's Proven 5-Step Formula For Sharper Memory Doesn't Depend On Supplements
A survey has proven that 1 in 4 adults is dependent on brain supplements to make their memory sharper. Here is what the research about brain supplements usage and their effectiveness and a 5-step formula to actually make your memory sharper.
-
Pig Organ Transplants May One Day Outperform Human Donors, Says Leading Surgeon
A US clinical trial using gene-edited pig kidneys has begun, with experts saying xenotransplantation could one day offer safer and more effective alternatives to human donor organs.
-
Elon Musk's Neuralink to Test Brain Chips in Clinical Study in Great Britain
Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts.
-
Can Artificial Intelligence Chatbots Really Improve Mental Health
Recently, I found myself pouring my heart out, not to a human, but to a chatbot named Wysa on my phone. It nodded - virtually - asked me how I was feeling and gently suggested trying breathing exercises.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
FDA Approves Suzetrigine, First Non-Opioid Painkiller in Decades
The FDA has approved suzetrigine, a groundbreaking painkiller that blocks sodium channels to provide opioid-level pain relief without the risks of addiction, sedation, or overdose. Known as Journavx, this drug is the first in over two decades to introduce a new pain relief mechanism. Clinical trials showed it matched opioids in effectiveness but wi...
-
Elon Musk's Neuralink Gets FDA's 'Breakthrough Device' Tag for Implant Aimed at Restoring Vision
Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the US Food and Drug Administration's "breakthrough device" designation.
-
Neuralink Brain Chip Implant Wires Now Stable in First Patient, Musk Hopes for More Human Trials This Year
Neuralink's first brain chip implant in a human has stabalised, company executives have confirmed this week. The device works by using tiny wires, which are thinner than a human hair, to capture signals from the brain and translate those into actions such as moving a mouse cursor on a computer screen.
